147 related articles for article (PubMed ID: 9634646)
1. Tolerance develops to the antinociceptive and motor impairing effects of ACEA-1416, a NMDA receptor antagonist, in the formalin and rotarod test in mice.
Lutfy K; Weber E
Pharmacol Res; 1998 Apr; 37(4):295-302. PubMed ID: 9634646
[TBL] [Abstract][Full Text] [Related]
2. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
Lutfy K; Doan P; Nguyen M; Weber E
Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
[TBL] [Abstract][Full Text] [Related]
3. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
Lutfy K; Shen KZ; Woodward RM; Weber E
Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice.
Lutfy K; Weber E
Brain Res; 1996 Dec; 743(1-2):17-23. PubMed ID: 9017225
[TBL] [Abstract][Full Text] [Related]
6. ACEA-1011, a novel NMDA receptor/glycine site antagonist, produces antinociception but not tolerance in the formalin test in mice.
Lutfy K; Keana JF; Weber E
NIDA Res Monogr; 1995; 147():220-33. PubMed ID: 8742789
[No Abstract] [Full Text] [Related]
7. Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test.
Lutfy K; Sadowski B; Marek P; Kwon IS; Keana JF; Weber E
Pharmacol Biochem Behav; 1996 Jun; 54(2):495-500. PubMed ID: 8743614
[TBL] [Abstract][Full Text] [Related]
8. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
Lutfy K; Doan P; Nugyen M; Weber E
Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
[TBL] [Abstract][Full Text] [Related]
9. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
Nishiyama T
Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
[TBL] [Abstract][Full Text] [Related]
10. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist.
Lutfy K; Shen KZ; Kwon IS; Cai SX; Woodward RM; Keana JF; Weber E
Eur J Pharmacol; 1995 Jan; 273(1-2):187-9. PubMed ID: 7737313
[TBL] [Abstract][Full Text] [Related]
11. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine receptor sites.
Coderre TJ; Van Empel I
Pain; 1994 Dec; 59(3):353-359. PubMed ID: 7708409
[TBL] [Abstract][Full Text] [Related]
12. Antinociception induced by CP 96,345, a non-peptide NK-1 receptor antagonist, in the mouse formalin and capsaicin tests.
Sakurada T; Katsumata K; Yogo H; Tan-No K; Sakurada S; Kisara K
Neurosci Lett; 1993 Mar; 151(2):142-5. PubMed ID: 7685073
[TBL] [Abstract][Full Text] [Related]
13. Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test.
Nishiyama T
Eur J Pharmacol; 2000 May; 395(3):203-10. PubMed ID: 10812050
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin.
Vaccarino AL; Marek P; Kest B; Weber E; Keana JF; Liebeskind JC
Brain Res; 1993 Jul; 615(2):331-4. PubMed ID: 8364741
[TBL] [Abstract][Full Text] [Related]
15. Interaction between a NMDA receptor antagonist, AP-5 and an AMPA receptor antagonist, YM 872 in antinociception in the spinal cord.
Nishiyama T
Acta Anaesthesiol Scand; 2008 Apr; 52(4):493-8. PubMed ID: 18339155
[TBL] [Abstract][Full Text] [Related]
16. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
[TBL] [Abstract][Full Text] [Related]
17. Peripheral administration of NR2 antagonists attenuates orofacial formalin-induced nociceptive behavior in rats.
Park MK; Lee JH; Yang GY; Won KA; Kim MJ; Park YY; Bae YC; Ahn DK
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):982-6. PubMed ID: 21295101
[TBL] [Abstract][Full Text] [Related]
18. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests.
Coderre TJ; Van Empel I
Pain; 1994 Dec; 59(3):345-352. PubMed ID: 7708408
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval.
Belozertseva IV; Dravolina OA; Neznanova ON; Danysz W; Bespalov AY
Eur J Pharmacol; 2000 May; 396(2-3):77-83. PubMed ID: 10822059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
